EVT-101 HCl

EVT-101 is a selective GluN2B subunit-containing NMDA receptor antagonist. Although it shares a binding site with ifenprodil, it engages a distinct subcavity with a unique interaction profile. This compound is a valuable pharmacological tool for investigating the role of GluN2B in neurological disorders, supporting both in vitro and in vivo neuroscience research.